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Abstract
Background: Chronic migraine is common but there is limited knowledge on associated comorbidities. Objec-
tives: To examine mental and physical comorbidities in chronic migraine and the influence of socioeconomic 
status in a large, nationally representative dataset. Design: Analysis of cross-sectional primary healthcare data 
from 1,468,404 adults in Scotland. Chronic migraine, 31 other physical conditions, and seven mental health con-
ditions we examined. Prevalence rates were standardized by age groups, sex, and socioeconomic deprivation, and 
adjusted odds ratio (aOR) and 95% confidence intervals (CI) calculated for those with chronic migraine com-
pared with those without. Results: Chronic migraine patients had more conditions, with the biggest difference 
found for five or more conditions (chronic migraine 11.7% vs. controls 4.9%; aOR 3.00; 95% CI 2.78–3.22). 
Twenty-five of the 31 physical conditions were significantly more prevalent in the chronic migraine group. The 
biggest difference was for chronic pain (aOR 4.33; 95% CI 4.12–4.55). For mental health conditions, the big-
gest differences were for anxiety (aOR 2.95; 95% CI 2.76–31.5) and depression (aOR 2.94; 95% CI 2.81–3.08). 
Increasing deprivation was associated with more severe and complex comorbidity (five or more conditions), and 
with more combined mental and physical comorbidity in the chronic migraine group. Conclusions: In a large 
nationally representative sample in primary care, comorbidity was most common in those with chronic migraine 
compared with standardized controls, and this was exacerbated by living in areas of higher deprivation.
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cause of disability worldwide [1]. Higher prevalence of 
migraine has also been associated with those living in 
poorer households [2,3] who have also been found to 
be more likely to have comorbidity and higher numbers 
of comorbid conditions [4]. Individuals with migraine 
have been reported to be more likely to have comorbid-
ity than the general population for a range of different 
types of conditions (e.g. stroke, chronic heart disease) 
[4,5].
However, most studies on comorbidity in migraine 
have focused on a limited number of individual comor-
bid conditions, such as migraine and comorbidity in 
stroke [6,7], heart disease [8,9], and certain mental 
health conditions [10–12]. There has been little work 
Introduction
Migraine is a common neurological disorder that usu-
ally begins in adolescence or early adult life. The World 
Health Organization has classified headache as a major 
health disorder and it has been rated as the sixth highest 
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that has examined the level of physical and mental health 
comorbidity in those with chronic migraine compared 
with those without, across a wide range of conditions.
Therefore, the aim of this study was to quantify the 
extent of comorbidity experienced by adults with chronic 
migraine compared with the general population, and to 
measure the associations between socioeconomic depri-
vation and comorbidity in those with chronic migraine.
Methods
We obtained data from the Primary Care Clinical 
Informatics Unit at the University of Aberdeen for 
all 1,468,404 patients aged ≥16 years who were alive 
and permanently registered with one of 314 Scottish 
general practices on March 31, 2007 [13]. We divided 
individuals into two groups according to whether they 
had chronic migraine or not, based on prescribing data 
(see below). Data on the presence of chronic migraine, 
31 other common chronic physical health conditions, 
and seven mental health conditions were extracted. 
The dataset is representative of the whole Scottish 
population in terms of age, sex, and socioeconomic 
deprivation, and has been detailed elsewhere [14]. We 
defined chronic migraine as being present in patients 
who had four or more anti-migraine prescriptions in 
the previous 12 months, as explained in our previous 
work on this  dataset [14].
To control for differences between the two popula-
tions in age, sex, and deprivation levels, we adopted a 
similar approach to that undertaken in previous papers 
[15–17], and generated standardized prevalence rates by 
age groups (16–24; 25–34; 35–44; 45–54; 55–64; 65–74 
and ≥75 years), sex, and deprivation quintile using the 
direct method. These age–sex–deprivation standard-
ized rates were then used to calculate adjusted odds 
ratio (aORs) and 95% confidence intervals (95% CI) 
for adults with chronic migraine compared with those 
without (controls), for the prevalence of 31 other phys-
ical conditions, seven other mental health conditions 
as well as by the number of overall conditions and the 
number of physical and mental health conditions.
Socioeconomic deprivation was measured using the 
Carstairs deprivation score divided into quintiles from 
the most affluent (1) to the most deprived (5). The 
Carstairs score is based on postcode of residence and is 
widely used in healthcare research as a measure of socio-
economic status [13].
There is no gold standard way of measuring severity or 
complexity of comorbidity. However, those with mental 
and physical comorbidity, or with five or more condi-
tions in total are likely to have more severe and complex 
problems requiring greater clinical support [18].
We used t-tests to analyse differences between groups 
and one-way analysis of variance for differences across age 
groups and deprivation quintiles. For all statistical analyses, 
a p-value less than 0.05 was considered statistically signifi-
cant. All analyses were performed in Stata version 13. The 
NHS Grampian Research Ethics Service approved the 
anonymous use of these data for research purposes.
Results
Demographics
There were 9,370 patients with chronic migraine based 
on our definition (Table 1). The chronic migraine group 
was more likely to be women compared with unad-
justed controls (85.0% vs. 50.6% for controls; p<0.001). 
Individuals with chronic migraine were on average 
older (mean age 50.5 years vs. 47.0 years for unadjusted 
controls; p<0.001). Little difference was found by distri-
butions in deprivation quintiles (Table 1).
Comorbidities
Overall, 24.8% of individuals with chronic migraine 
had no other condition compared with 52.6% of adjusted 
controls (aOR 0.33; 95% CI 0.32–0.35) (Table 2). Sig-
nificant differences between the chronic migraine and 
adjusted control groups showed that those with chronic 
migraine were more likely to have three, four, five, or 
more conditions. Differences widened with increasing 
number of conditions, with the biggest difference found 
for five or more conditions (chronic migraine 11.7% vs. 
controls 4.9%; aOR 3.00; 95% CI 2.78–3.22) (Table 2).
Table 1 Age, sex, and deprivation status for individuals with migraine 
versus controls.
Variable  Migraine, n (%)  No migraine, n (%)  p*
Total  9,370 (0.6)  1,459,034 (99.4)  
Female sex  7,961 (85.0)  738,197 (50.6)  <0.001
Mean age (SD), years  50.5 (13.2)  47.0 (18.7)  <0.001
Age group, years
 16–24
 25–34
 35–44
 45–54
 55–64
 65–74
 ≥75
 
363 (3.9)
718 (7.7)
1,710 (18.3)
2,874 (30.7)
2,482 (26.5)
923 (9.9)
300 (3.2)
 
195,356 (13.4)
228,678 (15.7)
277,283 (19.0)
250,920 (17.2)
216,851 (14.9)
154,357 (10.6)
135,589 (9.3)
 
<0.001
<0.001
0.06
<0.001
<0.001
0.02
<0.001
Deprivation quintile
 1 (least deprived)
 2
 3
 4
 5 (most deprived)
 
1,706 (18.2)
1,928 (20.6)
2,172 (23.2)
1,839 (19.6)
1,725 (18.4)
 
278,508 (19.1)
311,710 (21.4)
330,113 (22.6)
277,924 (19.0)
260,779 (17.9)
 
0.03
0.06
0.20
0.15
0.17
*Based on t-tests. SD, standard deviation.
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Table 2 Prevalence and adjusted odds ratios for number and type of comorbidities (standardized by age, sex, and deprivation score).
Variable  Migraine 
n (%)
No migraine 
n (%)
Adjusted odds ratio (95% CI) 
Total number of individuals  9,370 (0.6) 1,459,034 (99.4) 
Total number of morbidities*
 0
 1
 2
 3
 4
 ≥5 or more
 
2,325 (24.8)
2,092 (22.3)
1,717 (18.3)
1,276 (13.6)
868 (9.3)
1,092 (11.7)
 
767,609 (52.6)
304,281 (20.9)
161,388 (11.1)
96,049 (6.6)
57,821 (4.0)
71,886 (4.9)
 
0.33 (0.32–0.35)
0.90 (0.86–0.95)
1.47 (1.39–1.55)
1.97 (1.85–2.10)
2.35 (2.18–2.54)
3.00 (2.78–3.22)
Total number of physical conditions*
 0
 1
 2
 3
 4
 ≥5
 
2,903 (31.0)
2,494 (26.6)
1,750 (18.7)
1,076 (11.5)
596 (6.4)
551 (5.9)
 
838,170 (57.5)
295,757 (20.3)
147,780 (10.1)
82,723 (5.7)
46,540 (3.2)
48,064 (3.3)
 
0.36 (0.34–0.37)
1.14 (1.09–1.19)
1.68 (1.59–1.77)
2.04 (1.90–2.18)
2.19 (2.00–2.35)
2.45 (2.22–2.70)
Total number of mental health conditions
 0
 1
 ≥2
 
5,953 (63.5)
2,417 (25.8)
1,000 (10.7)
 
406,379 (85.3)
163,390 (11.2)
50,777 (3.5)
 
0.37 (0.36–0.39)
2.18 (1.92–2.27)
2.67 (2.49–2.85)
All differences significant at p<0.001. *Excluding migraine. CI, confidence interval.
Restricting the analysis to only physical health comor-
bidities showed a similar trend to that of total number 
of conditions, although the differences were slightly 
smaller. Those with chronic migraine were far less likely 
to have no physical conditions (migraine 31.0% vs. con-
trols 57.5%; aOR 0.36; 95% CI 0.34–0.37), with the 
biggest difference found for five or more physical con-
ditions (chronic migraine 5.9% vs. controls 3.3%; aOR 
2.45; 95% CI 2.20–2.70).
Table 2 also shows high levels of co-occurring men-
tal health in the chronic migraine group, with 36.5% 
having at least one mental health condition. Peo-
ple with chronic migraine were less likely to have no 
recorded mental health condition compared with con-
trols (chronic migraine 63.5% vs. controls 85.0%; aOR 
0.37; 95% CI 0.36–0.39) and more than twice as likely 
to have one (chronic migraine 25.8% vs. controls 11.2%; 
aOR 2.18; 95% CI 1.92–2.27) and two or more (chronic 
migraine 10.7% vs. controls 3.5%; aOR 2.67; 95% CI 
2.49–2.85).
Physical health conditions
For the chronic migraine group, 25 out of 31 physical 
conditions were significantly more prevalent relative to 
controls after standardization for age, sex, and depri-
vation, with six conditions showing no significant 
difference and no conditions significantly less prevalent 
(Table 3). The biggest differences after standardization 
for age, sex, and deprivation were for painful condition 
(aOR 4.33; 95% CI 4.12–4.55) and constipation (aOR 
2.98; 95% CI 2.72–3.26). Five other conditions (dyspep-
sia, prostate disease, irritable bowel syndrome, epilepsy, 
chronic sinusitis) were more than twice as likely to be 
found in those with chronic migraine following stan-
dardization for age, sex, and deprivation. High raw 
prevalence rates were found for the chronic migraine 
group for painful condition (32.1%), hypertension 
(19.2%), and dyspepsia (13.9%).
Mental health conditions
Table 4 shows that those with chronic migraine had 
significantly higher prevalence for three of the seven 
mental health conditions, with no significant differ-
ence found for the remaining four. After standardization 
for age, sex, and deprivation, both anxiety and depres-
sion were almost three times as likely to be found in 
the chronic migraine group; anxiety (chronic migraine 
12.1% vs. controls 3.8%; aOR 2.95; 95% CI 2.76–3.15) 
and depression (migraine 31.3% vs. controls 9.7%; aOR 
2.94; 95% CI 2.81–3.08).
Effect of deprivation
Figure 1 shows the effect of deprivation on the num-
ber of individuals with five or more conditions (upper 
panel) and those with at least one physical and one 
mental health condition using age–sex standardized 
rates (lower panel). For both measures, the trend is 
similar with steeper rises in prevalence, with increas-
ing deprivation found for chronic migraine compared 
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Table 3 Prevalence and adjusted odds ratios for individual physical conditions (standardized by age, sex, and deprivation score). Conditions are ordered 
by size of odds ratio (largest to smallest).
Condition  Migraine 
n (%)
No migraine 
n (%)
Adjusted odds ratio (95% CI) 
Total number of individuals  9,370 (0.6) 1,459,034 (99.4) 
Painful condition  3,005 (32.1) 123,229 (8.5) 4.33 (4.12–4.55)
Constipation  587 (6.3) 35,913 (2.5) 2.98 (2.72–3.26)
Dyspepsia  1,300 (13.9) 77,993 (5.4) 2.42 (2.27–2.57)
Prostate disease  58 (0.6) 15,176 (1.0) 2.24 (1.72–2.91)
Irritable bowel syndrome  1,047 (11.2) 51,286 (3.5) 2.22 (2.08–2.37)
Epilepsy  186 (2.0) 12,379 (0.9) 2.19 (1.89–2.54)
Chronic sinusitis  167 (1.8) 9,027 (0.6) 2.11 (1.81–2.47)
Active asthma  1,163 (12.4) 86,587 (5.9) 1.95 (1.84–2.08)
Multiple sclerosis  81 (0.9) 3,768 (0.3) 1.94 (1.55–2.42)
Stroke or transient ischaemic attack  281 (3.0) 36,279 (2.5) 1.66 (1.47–1.88)
Psoriasis or eczema  103 (1.1) 10,451 (0.7) 1.57 (1.29–1.91)
Bronchiectasis  31 (0.3) 2,793 (0.2) 1.53 (1.07–21.9); p=0.01
Inflammatory arthritis and related conditions, including gout  581 (6.2) 57,600 (4.0) 1.52 (1.39–1.65)
Inflammatory bowel disease  111 (1.2) 9,686 (0.7) 1.52 (1.25–1.83)
Thyrotoxicosis/thyroid disorders, including hypothyroidism  1,006 (10.7) 71,077 (4.9) 1.44 (1.35–1.54)
Diverticular disease  286 (3.1) 33,530 (2.3) 1.43 (1.26–1.61)
Any new cancer in the last 5 years  404 (4.3) 43,422 (3.0) 1.36 (1.23–1.50)
Hearing loss  398 (4.3) 55,333 (3.7) 1.34 (1.21–1.49)
Peripheral vascular disease  170 (1.8) 23,122 (1.6) 1.29 (1.10–1.50)
Diabetes  569 (6.1) 74,524 (5.1) 1.23 (1.13–1.35)
Viral hepatitis  8 (0.1) 1,167 (0.1) 1.23 (0.61–2.48); p=0.55
Chronic kidney disease  205 (2.2) 33,362 (2.3) 1.23 (1.07–1.43)
Visual impairment  50 (2.9) 8,485 (0.6) 1.22 (0.92–1.62)
Coronary heart disease  64 (0.7) 81,019 (5.6) 1.21 (1.10–1.34)
Hypertension  1,798 (19.2) 232,538 (15.9) 1.18 (1.11–1.25)
Atrial fibrillation  91 (1.0) 23,887 (1.6) 1.02 (0.82–1.26); p=0.83
Glaucoma  84 (0.9) 15,844 (1.1) 1.01 (0.81–1.26); p=0.88
Parkinson’s disease  10 (0.1) 2,732 (0.2) 1.00 (0.53–1.87); p=0.99
Heart failure  178 (6.7) 18,840 (1.3) 0.80 (0.62–1.02); p=0.08
Cirrhosis/chronic liver disease/alcoholic liver disease  11 (0.1) 2,603 (0.2) 0.64 (0.35–1.45); p=0.14
All differences significant at p<0.001, except where stated.
Table 4 Prevalence and adjusted odds ratios for individual mental health conditions (standardized by age, sex, and deprivation score). Conditions are 
ordered by size of odds ratio (largest to smallest).
Condition  Migraine, 
n (%)
 No migraine, 
n (%)
 Adjusted odds ratio (95% CI) 
Total number of individuals  9,370 (0.6)  1,459,034 (99.4)  
Anxiety and other neurotic conditions, stress-related and somatoform 
disorders
 1,131 (12.1)  54,763 (3.8)  2.95 (2.76–3.15)
Depression  2,932 (31.3)  141,245 (9.7)  2.94 (2.81–3.08)
Anorexia or bulimia  71 (0.8)  5,295 (0.4)  1.48 (1.17–1.87)
Learning disability  43 (0.5)  5,040 (0.4)  1.28 (0.94–1.73); p=0.11
Schizophrenia (and related non-organic psychosis) or bipolar disorder  102 (1.1)  12,396 (0.9)  1.09 (0.89–1.33); p=0.38
Alcohol misuse  220 (2.4)  42,340 (2.9)  0.92 (0.81–1.05); p=0.24
Dementia  39 (0.4)  11,664 (0.8)  0.83 (0.60–1.15); p=0.27
All differences significant at p<0.001 except where stated.
with controls (p<0.001). For example, for those with 
five or more conditions, the difference between the 
least and most deprived quintiles in those with chronic 
migraine was least deprived 377 (22.1%) vs. most 
deprived 649 (37.6%); p<0.00, and in the controls, 
it was least deprived 20,553 (7.2%) vs. most deprived 
32,597 (12.5%); (p<0.001). For those with at least one 
physical and at least one mental health condition and 
with chronic migraine, it was least deprived 106 (6.2%) 
vs. most deprived 236 (13.7%); (p<0.001), and in the 
controls, it was least deprived 10,583 (3.8%) vs. most 
deprived 15,386 (5.9%); (p<0.001).
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Discussion
We analysed comorbidity using primary healthcare data 
on patients with chronic migraine compared with those 
without chronic migraine (adjusted for age, sex, and 
deprivation), in a large nationally representative data-
set that included a wide range of physical and mental 
comorbid conditions. The chronic migraine group were 
significantly more likely to have more comorbidity, with 
the biggest difference found for five or more conditions. 
In total, 25 of the 31 physical conditions were signifi-
cantly more prevalent in the chronic migraine group. 
The biggest difference was for chronic pain, which was 
over four times more common in the chronic migraine 
group compared with (adjusted) controls. Three of the 
seven mental health conditions were also significantly 
more prevalent in the chronic migraine group. Increas-
ing deprivation was associated with more comorbidity 
that was likely to be more severe and complex (five or 
more conditions, and combined mental and physical 
conditions) in the chronic migraine group [18].
The current study had strengths and weaknesses. 
Strengths included the large and nationally represent-
ative nature of the dataset, the fact it was primary care 
based, and the wide range of physical and mental condi-
tions included. Analysis of the data by deprivation level 
was also a strength, as this is an often-neglected area 
of enquiry. Weaknesses include the fact that the data 
were cross-sectional, and there were no outcome data 
available. The classification of chronic migraine was also 
made on the basis of prescribing data, which may not 
give a true prevalence. Prescribing data in Scotland are 
highly accurate as all prescriptions are computer-based, 
but it is possible that there were some patients with 
chronic migraine who were not receiving anti-migraine 
medication.
In relation to the published literature on the topic, 
comparison of the current study with others is difficult, 
as many of the previous studies have been smaller, have 
not been primary care based, and have not included 
such a wide range of mental and physical comorbid con-
ditions. They also have seldom differentiated between 
acute and chronic migraine. In a population-based 
study, Jette et al. [2] found that migraine prevalence 
was higher in people with lower socioeconomic status, 
but that comorbidities were not related to socioeco-
nomic status; whereas in the current study, we found 
the opposite of this. In a review of comorbidities in 
migraine, Wang et al. [5] found that migraine was 
related to stroke, and possibly to coronary heart dis-
ease, which was found in the current study. They also 
reported increases in several mental health conditions, 
such as depression and anxiety, which were reflected in 
the current study. Psychiatric problems in migraine are 
common and worsen outcomes of treatment [19]. We 
found a higher prevalence of anorexia, which has not 
previously been reported. In relation to the other phys-
ical conditions, our increased prevalence of epilepsy, 
pain, irritable bowel syndrome, diabetes, and asthma in 
chronic migraine in the present study is in line with 
previous findings [5]. Higher rates of constipation, 
cancer, thyroid disease, dyspepsia, diverticular disease, 
inflammatory bowel disease, inflammatory arthritis, 
and psoriasis/eczema were also detected in those with 
migraine compared with standardized controls.
In terms of implications for research and practice, there 
is much research needed to be done to explore the mech-
anisms behind the higher level of comorbidity in patients 
with chronic migraine. Health service providers need to 
deliver a holistic approach to the care of such patients, 
with an appropriate balance of specialist and generalist 
input. The social patterning of complex comorbidities 
in chronic migraine, with much higher levels in more 
deprived areas, is important in view of the continuing 
problem of the inverse care law [18]. This inverse care 
law states that because of the mismatch of unmet need 
and supply in deprived areas, doctors are more stressed 
and less patient-centred, and consultations are shorter 
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Figure 1 Age–sex-standardized prevalence rates by deprivation 
quintile.
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compared with more affluent settings, and patients with 
complex needs are less enabled and have poorer outcomes 
[20,21]. Studies have not been specifically conducted on 
chronic migraine sufferers in deprived areas, but it seems 
very likely that the inverse care law will operate in the 
same way in this group as it does generally. Experimentally 
reversing the inverse care law by providing longer con-
sultation, a patient-centred approach, continuity of care, 
and support for practitioners has recently been shown to 
improve quality of life in patients with severe multimor-
bidity in deprived areas, in a cost-effective way [22].
Conclusions
In conclusion, in a large nationally representative sam-
ple in primary care, comorbidity was more common 
in people living with chronic migraine compared with 
standardized controls, and this was exacerbated by liv-
ing in areas of higher deprivation. Such patients need 
integrated patient-centred care that provides a holistic 
generalist approach.
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